SCHEDULE: Ayrton Capital Discloses 7.12% Stake in Nano Labs
Beneficial Ownership Report
Ayrton Capital LLC and its affiliates have reported a 7.12% beneficial ownership stake in Nano Labs Ltd, comprising common shares and warrants.
Summary
- Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri collectively reported beneficial ownership of 1,542,929 Class A ordinary shares of Nano Labs Ltd.
- This ownership represents 7.12% of the outstanding Class A ordinary shares.
- The stake consists of 590,548 directly held shares and 952,381 shares issuable upon the exercise of certain warrants.
- The shares issuable from warrants are subject to a 9.99% beneficial ownership blocker.
- The percentage is calculated based on 20,712,924 shares of Common Stock outstanding as of June 27, 2025, as stated in the Issuer's Prospectus Supplement Form 424B5.
Sentiment
Score: 7
Explanation: The disclosure of a significant beneficial ownership stake by an investment manager and fund generally indicates confidence in the company's prospects, which is a positive signal for the market.
Positives
- The disclosure of a significant beneficial ownership stake by an investment manager and fund can signal institutional confidence in Nano Labs Ltd's prospects.
Risks
- The exercise of certain warrants held by the reporting persons is subject to a 9.99% beneficial ownership blocker, limiting immediate full conversion.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Increased institutional ownership may enhance investor confidence and potentially improve liquidity for shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/27/2025 | Date of Issuer's Prospectus Supplement Form 424B5, stating 20,712,924 shares outstanding. |
| 06/30/2025 | Date of event which requires the filing of this statement. |
| 08/13/2025 | Filing date of the Schedule 13G. |
Recommendation
holdThe filing indicates a significant beneficial ownership stake by Ayrton Capital LLC and its affiliates in Nano Labs Ltd, signaling institutional confidence. While this is a positive indicator, a Schedule 13G filing primarily discloses ownership and does not provide comprehensive financial or operational details necessary for a definitive 'buy' or 'sell' recommendation. Investors should 'hold' and conduct further due diligence on Nano Labs Ltd's fundamentals, financial performance, and strategic outlook before making investment decisions.
Keywords
Nano Labs, Ayrton Capital, Alto Opportunity Master Fund, Waqas Khatri, beneficial ownership, Schedule 13G, Class A ordinary shares, institutional investment, warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.